Clinical Trial

A Study of DC6001 Tablet in Healthy Chinese Adult Subjects

Name: A Study of DC6001 Tablet in Healthy Chinese Adult Subjects — clinical trial record (NCT07417566)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This study adopts a randomized, double-blind, parallel placebo-controlled dose-escalation design, consisting of two parts: Part 1 includes a single ascending dose (SAD) study plus a food effect (FE) study, and Part 2 is a multiple ascending dose (MAD) study.

Trial Details

NCT Number	NCT07417566
Lead Sponsor	Heronova Pharmaceuticals
Conditions	Stargardt Disease
Enrollment	76 participants
Start Date	2026-01-01
Primary Completion	2026-12-31 (estimated)
Study Completion	2026-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-02-18